APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Lacosamide Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Lacosamide Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174006230327 December 2025199 pages

Choose your research edition.

Industry ResearchLacosamide Drugs Industry Research Report 2026148 pages · $2,950 USDIndustry Growth & TrendsGlobal Lacosamide Drugs Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Lacosamide Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lacosamide Drugs Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Lacosamide Drugs Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

The global Lacosamide Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Lacosamide Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Lacosamide Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Lacosamide Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Lacosamide Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Lacosamide Drugs include Zhejiang Huahai Pharmaceutical, CSPC Ouyi Pharmaceutical, Shijiazhuang No.4 Pharmaceutical, Shandong Loncom Pharmaceutical, Jiangxi Qingfeng Pharmaceutical, Jiangsu Haian Pharmaceutical, Jianmin Group, Hefei Yifan Biopharmaceuticals and Buchang Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Lacosamide Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Lacosamide Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Lacosamide Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Lacosamide Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Lacosamide Drugs Segment by Company

Zhejiang Huahai Pharmaceutical

CSPC Ouyi Pharmaceutical

Shijiazhuang No.4 Pharmaceutical

Shandong Loncom Pharmaceutical

Jiangxi Qingfeng Pharmaceutical

Jiangsu Haian Pharmaceutical

Jianmin Group

Hefei Yifan Biopharmaceuticals

Buchang Pharmaceutical

Beijing Sihuan Pharmaceutical

UCB Pharma

Teva

Sun Pharma

Sandoz

Mylan

Glenmark Pharmaceuticals

Camber Pharma

Aucta Pharma

Apotex

Actavis

Lacosamide Drugs Segment by Type

Oral Solution

Tablets

Injection

Lacosamide Drugs Segment by Application

Hospital and Clinic

Retail Pharmacies

Other

Lacosamide Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lacosamide Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lacosamide Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lacosamide Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Lacosamide Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Lacosamide Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Lacosamide Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Lacosamide Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Lacosamide Drugs Industry Trends Table 2. Lacosamide Drugs Industry Drivers Table 3. Lacosamide Drugs Industry Opportunities and Challenges Table 4. Lacosamide Drugs Industry Restraints Table 5. Global Lacosamide Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Lacosamide Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Lacosamide Drugs Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Lacosamide Drugs Sales Market Share by Manufacturers Table 9. Global Lacosamide Drugs Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Lacosamide Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Lacosamide Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Lacosamide Drugs Manufacturers, Product Type & Application Table 13. Global Lacosamide Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Lacosamide Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Oral Solution Table 17. Major Manufacturers of Tablets Table 18. Major Manufacturers of Injection Table 19. Global Lacosamide Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Lacosamide Drugs Sales by Type (2021-2026) & (K Units) Table 21. Global Lacosamide Drugs Sales by Type (2027-2032) & (K Units) Table 22. Global Lacosamide Drugs Sales Market Share by Type (2021-2026) Table 23. Global Lacosamide Drugs Sales Market Share by Type (2027-2032) Table 24. Global Lacosamide Drugs Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Lacosamide Drugs Revenue by Type (2021-2026) & (K Units) Table 26. Global Lacosamide Drugs Revenue by Type (2027-2032) & (K Units) Table 27. Global Lacosamide Drugs Revenue Market Share by Type (2021-2026) Table 28. Global Lacosamide Drugs Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Hospital and Clinic Table 30. Major Manufacturers of Retail Pharmacies Table 31. Major Manufacturers of Other Table 32. Global Lacosamide Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Lacosamide Drugs Sales by Application (2021-2026) & (K Units) Table 34. Global Lacosamide Drugs Sales by Application (2027-2032) & (K Units) Table 35. Global Lacosamide Drugs Sales Market Share by Application (2021-2026) Table 36. Global Lacosamide Drugs Sales Market Share by Application (2027-2032) Table 37. Global Lacosamide Drugs Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Lacosamide Drugs Revenue by Application (2021-2026) & (K Units) Table 39. Global Lacosamide Drugs Revenue by Application (2027-2032) & (K Units) Table 40. Global Lacosamide Drugs Revenue Market Share by Application (2021-2026) Table 41. Global Lacosamide Drugs Revenue Market Share by Application (2027-2032) Table 42. Global Lacosamide Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Lacosamide Drugs Sales by Region (2021-2026) & (K Units) Table 44. Global Lacosamide Drugs Sales Market Share by Region (2021-2026) Table 45. Global Lacosamide Drugs Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Lacosamide Drugs Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Lacosamide Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Lacosamide Drugs Sales by Country (2021-2026) & (K Units) Table 49. North America Lacosamide Drugs Sales by Country (2027-2032) & (K Units) Table 50. Europe Lacosamide Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Lacosamide Drugs Sales by Country (2021-2026) & (K Units) Table 52. Europe Lacosamide Drugs Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Lacosamide Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Lacosamide Drugs Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Lacosamide Drugs Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Lacosamide Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Lacosamide Drugs Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Lacosamide Drugs Sales by Country (2027-2032) & (K Units) Table 59. Global Lacosamide Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Lacosamide Drugs Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Lacosamide Drugs Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Lacosamide Drugs Revenue Market Share by Region (2021-2026) Table 63. Global Lacosamide Drugs Revenue Market Share by Region (2027-2032) Table 64. Zhejiang Huahai Pharmaceutical Company Information Table 65. Zhejiang Huahai Pharmaceutical Business Overview Table 66. Zhejiang Huahai Pharmaceutical Lacosamide Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Zhejiang Huahai Pharmaceutical Lacosamide Drugs Product Portfolio Table 68. Zhejiang Huahai Pharmaceutical Recent Development Table 69. CSPC Ouyi Pharmaceutical Company Information Table 70. CSPC Ouyi Pharmaceutical Business Overview Table 71. CSPC Ouyi Pharmaceutical Lacosamide Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. CSPC Ouyi Pharmaceutical Lacosamide Drugs Product Portfolio Table 73. CSPC Ouyi Pharmaceutical Recent Development Table 74. Shijiazhuang No.4 Pharmaceutical Company Information Table 75. Shijiazhuang No.4 Pharmaceutical Business Overview Table 76. Shijiazhuang No.4 Pharmaceutical Lacosamide Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Shijiazhuang No.4 Pharmaceutical Lacosamide Drugs Product Portfolio Table 78. Shijiazhuang No.4 Pharmaceutical Recent Development Table 79. Shandong Loncom Pharmaceutical Company Information Table 80. Shandong Loncom Pharmaceutical Business Overview Table 81. Shandong Loncom Pharmaceutical Lacosamide Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Shandong Loncom Pharmaceutical Lacosamide Drugs Product Portfolio Table 83. Shandong Loncom Pharmaceutical Recent Development Table 84. Jiangxi Qingfeng Pharmaceutical Company Information Table 85. Jiangxi Qingfeng Pharmaceutical Business Overview Table 86. Jiangxi Qingfeng Pharmaceutical Lacosamide Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Jiangxi Qingfeng Pharmaceutical Lacosamide Drugs Product Portfolio Table 88. Jiangxi Qingfeng Pharmaceutical Recent Development Table 89. Jiangsu Haian Pharmaceutical Company Information Table 90. Jiangsu Haian Pharmaceutical Business Overview Table 91. Jiangsu Haian Pharmaceutical Lacosamide Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Jiangsu Haian Pharmaceutical Lacosamide Drugs Product Portfolio Table 93. Jiangsu Haian Pharmaceutical Recent Development Table 94. Jianmin Group Company Information Table 95. Jianmin Group Business Overview Table 96. Jianmin Group Lacosamide Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Jianmin Group Lacosamide Drugs Product Portfolio Table 98. Jianmin Group Recent Development Table 99. Hefei Yifan Biopharmaceuticals Company Information Table 100. Hefei Yifan Biopharmaceuticals Business Overview Table 101. Hefei Yifan Biopharmaceuticals Lacosamide Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Hefei Yifan Biopharmaceuticals Lacosamide Drugs Product Portfolio Table 103. Hefei Yifan Biopharmaceuticals Recent Development Table 104. Buchang Pharmaceutical Company Information Table 105. Buchang Pharmaceutical Business Overview Table 106. Buchang Pharmaceutical Lacosamide Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Buchang Pharmaceutical Lacosamide Drugs Product Portfolio Table 108. Buchang Pharmaceutical Recent Development Table 109. Beijing Sihuan Pharmaceutical Company Information Table 110. Beijing Sihuan Pharmaceutical Business Overview Table 111. Beijing Sihuan Pharmaceutical Lacosamide Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Beijing Sihuan Pharmaceutical Lacosamide Drugs Product Portfolio Table 113. Beijing Sihuan Pharmaceutical Recent Development Table 114. UCB Pharma Company Information Table 115. UCB Pharma Business Overview Table 116. UCB Pharma Lacosamide Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. UCB Pharma Lacosamide Drugs Product Portfolio Table 118. UCB Pharma Recent Development Table 119. Teva Company Information Table 120. Teva Business Overview Table 121. Teva Lacosamide Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Teva Lacosamide Drugs Product Portfolio Table 123. Teva Recent Development Table 124. Sun Pharma Company Information Table 125. Sun Pharma Business Overview Table 126. Sun Pharma Lacosamide Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Sun Pharma Lacosamide Drugs Product Portfolio Table 128. Sun Pharma Recent Development Table 129. Sandoz Company Information Table 130. Sandoz Business Overview Table 131. Sandoz Lacosamide Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Sandoz Lacosamide Drugs Product Portfolio Table 133. Sandoz Recent Development Table 134. Mylan Company Information Table 135. Mylan Business Overview Table 136. Mylan Lacosamide Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. Mylan Lacosamide Drugs Product Portfolio Table 138. Mylan Recent Development Table 139. Glenmark Pharmaceuticals Company Information Table 140. Glenmark Pharmaceuticals Business Overview Table 141. Glenmark Pharmaceuticals Lacosamide Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 142. Glenmark Pharmaceuticals Lacosamide Drugs Product Portfolio Table 143. Glenmark Pharmaceuticals Recent Development Table 144. Camber Pharma Company Information Table 145. Camber Pharma Business Overview Table 146. Camber Pharma Lacosamide Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 147. Camber Pharma Lacosamide Drugs Product Portfolio Table 148. Camber Pharma Recent Development Table 149. Aucta Pharma Company Information Table 150. Aucta Pharma Business Overview Table 151. Aucta Pharma Lacosamide Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 152. Aucta Pharma Lacosamide Drugs Product Portfolio Table 153. Aucta Pharma Recent Development Table 154. Apotex Company Information Table 155. Apotex Business Overview Table 156. Apotex Lacosamide Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 157. Apotex Lacosamide Drugs Product Portfolio Table 158. Apotex Recent Development Table 159. Actavis Company Information Table 160. Actavis Business Overview Table 161. Actavis Lacosamide Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 162. Actavis Lacosamide Drugs Product Portfolio Table 163. Actavis Recent Development Table 164. Key Raw Materials Table 165. Raw Materials Key Suppliers Table 166. Lacosamide Drugs Distributors List Table 167. Lacosamide Drugs Customers List Table 168. Research Programs/Design for This Report Table 169. Authors List of This Report Table 170. Secondary Sources Table 171. Primary Sources List of Figures Figure 1. Lacosamide Drugs Product Image Figure 2. Global Lacosamide Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lacosamide Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Lacosamide Drugs Sales (2021-2032) & (K Units) Figure 5. Global Lacosamide Drugs Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Lacosamide Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Oral Solution Image Figure 9. Tablets Image Figure 10. Injection Image Figure 11. Global Lacosamide Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Lacosamide Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Lacosamide Drugs Sales Market Share by Type (2021-2032) Figure 14. Global Lacosamide Drugs Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Lacosamide Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Lacosamide Drugs Revenue Market Share by Type (2021-2032) Figure 17. Hospital and Clinic Image Figure 18. Retail Pharmacies Image Figure 19. Other Image Figure 20. Global Lacosamide Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Lacosamide Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Lacosamide Drugs Sales Market Share by Application (2021-2032) Figure 23. Global Lacosamide Drugs Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Lacosamide Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Lacosamide Drugs Revenue Market Share by Application (2021-2032) Figure 26. North America Lacosamide Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Lacosamide Drugs Sales Market Share by Country (2021-2032) Figure 28. U.S. Lacosamide Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Lacosamide Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Lacosamide Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Lacosamide Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Lacosamide Drugs Sales Market Share by Country (2021-2032) Figure 33. Germany Lacosamide Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Lacosamide Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Lacosamide Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Lacosamide Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Lacosamide Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Lacosamide Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Lacosamide Drugs Sales Market Share by Country (2021-2032) Figure 40. China Lacosamide Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Lacosamide Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Lacosamide Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Lacosamide Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Lacosamide Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Lacosamide Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Lacosamide Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Lacosamide Drugs Sales Market Share by Country (2021-2032) Figure 48. Brazil Lacosamide Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Lacosamide Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Lacosamide Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Lacosamide Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Lacosamide Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Lacosamide Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Lacosamide Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Lacosamide Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Lacosamide Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Lacosamide Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Lacosamide Drugs Revenue (2021-2032) & (US$ Million) Figure 59. North America Lacosamide Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Lacosamide Drugs Revenue (2021-2032) & (US$ Million) Figure 61. Europe Lacosamide Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Lacosamide Drugs Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Lacosamide Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Lacosamide Drugs Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Lacosamide Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Lacosamide Drugs Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Lacosamide Drugs Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Oral Solution
  • Tablets
  • Injection
Applications
  • Hospital and Clinic
  • Retail Pharmacies
  • Other
Companies covered
  • Zhejiang Huahai Pharmaceutical
  • CSPC Ouyi Pharmaceutical
  • Shijiazhuang No.4 Pharmaceutical
  • Shandong Loncom Pharmaceutical
  • Jiangxi Qingfeng Pharmaceutical
  • Jiangsu Haian Pharmaceutical
  • Jianmin Group
  • Hefei Yifan Biopharmaceuticals
  • Buchang Pharmaceutical
  • Beijing Sihuan Pharmaceutical
  • UCB Pharma
  • Teva
  • Sun Pharma
  • Sandoz
  • Mylan
  • Glenmark Pharmaceuticals
  • Camber Pharma
  • Aucta Pharma
  • Apotex
  • Actavis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Lacosamide Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Lacosamide Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Lacosamide Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Lacosamide Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Lacosamide Drugs Market Dynamics
  1. 2.1 Lacosamide Drugs Industry Trends
  2. 2.2 Lacosamide Drugs Industry Drivers
  3. 2.3 Lacosamide Drugs Industry Opportunities and Challenges
  4. 2.4 Lacosamide Drugs Industry Restraints
3 Lacosamide Drugs Market by Manufacturers
  1. 3.1 Global Lacosamide Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Lacosamide Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Lacosamide Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Lacosamide Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Lacosamide Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Lacosamide Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Lacosamide Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Lacosamide Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Lacosamide Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Lacosamide Drugs Tier 1, Tier 2, and Tier 3
4 Lacosamide Drugs Market by Type
  1. 4.1 Lacosamide Drugs Type Introduction
  2. 4.1.1 Oral Solution
  3. 4.1.2 Tablets
  4. 4.1.3 Injection
  5. 4.2 Global Lacosamide Drugs Sales by Type
  6. 4.2.1 Global Lacosamide Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Lacosamide Drugs Sales by Type (2021-2032)
  8. 4.2.3 Global Lacosamide Drugs Sales Market Share by Type (2021-2032)
  9. 4.3 Global Lacosamide Drugs Revenue by Type
  10. 4.3.1 Global Lacosamide Drugs Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Lacosamide Drugs Revenue by Type (2021-2032)
  12. 4.3.3 Global Lacosamide Drugs Revenue Market Share by Type (2021-2032)
5 Lacosamide Drugs Market by Application
  1. 5.1 Lacosamide Drugs Application Introduction
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Retail Pharmacies
  4. 5.1.3 Other
  5. 5.2 Global Lacosamide Drugs Sales by Application
  6. 5.2.1 Global Lacosamide Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Lacosamide Drugs Sales by Application (2021-2032)
  8. 5.2.3 Global Lacosamide Drugs Sales Market Share by Application (2021-2032)
  9. 5.3 Global Lacosamide Drugs Revenue by Application
  10. 5.3.1 Global Lacosamide Drugs Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Lacosamide Drugs Revenue by Application (2021-2032)
  12. 5.3.3 Global Lacosamide Drugs Revenue Market Share by Application (2021-2032)
6 Global Lacosamide Drugs Sales by Region
  1. 6.1 Global Lacosamide Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Lacosamide Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Lacosamide Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Lacosamide Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Lacosamide Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Lacosamide Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Lacosamide Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Lacosamide Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Lacosamide Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Lacosamide Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Lacosamide Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Lacosamide Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Lacosamide Drugs Revenue by Region
  1. 7.1 Global Lacosamide Drugs Revenue by Region
  2. 7.1.1 Global Lacosamide Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Lacosamide Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Lacosamide Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Lacosamide Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Lacosamide Drugs Revenue (2021-2032)
  8. 7.2.2 North America Lacosamide Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Lacosamide Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Lacosamide Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Lacosamide Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Lacosamide Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Lacosamide Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Lacosamide Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Zhejiang Huahai Pharmaceutical
  2. 8.1.1 Zhejiang Huahai Pharmaceutical Company Information
  3. 8.1.2 Zhejiang Huahai Pharmaceutical Business Overview
  4. 8.1.3 Zhejiang Huahai Pharmaceutical Lacosamide Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zhejiang Huahai Pharmaceutical Lacosamide Drugs Product Portfolio
  6. 8.1.5 Zhejiang Huahai Pharmaceutical Recent Developments
  7. 8.2 CSPC Ouyi Pharmaceutical
  8. 8.2.1 CSPC Ouyi Pharmaceutical Company Information
  9. 8.2.2 CSPC Ouyi Pharmaceutical Business Overview
  10. 8.2.3 CSPC Ouyi Pharmaceutical Lacosamide Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 CSPC Ouyi Pharmaceutical Lacosamide Drugs Product Portfolio
  12. 8.2.5 CSPC Ouyi Pharmaceutical Recent Developments
  13. 8.3 Shijiazhuang No.4 Pharmaceutical
  14. 8.3.1 Shijiazhuang No.4 Pharmaceutical Company Information
  15. 8.3.2 Shijiazhuang No.4 Pharmaceutical Business Overview
  16. 8.3.3 Shijiazhuang No.4 Pharmaceutical Lacosamide Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Shijiazhuang No.4 Pharmaceutical Lacosamide Drugs Product Portfolio
  18. 8.3.5 Shijiazhuang No.4 Pharmaceutical Recent Developments
  19. 8.4 Shandong Loncom Pharmaceutical
  20. 8.4.1 Shandong Loncom Pharmaceutical Company Information
  21. 8.4.2 Shandong Loncom Pharmaceutical Business Overview
  22. 8.4.3 Shandong Loncom Pharmaceutical Lacosamide Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Shandong Loncom Pharmaceutical Lacosamide Drugs Product Portfolio
  24. 8.4.5 Shandong Loncom Pharmaceutical Recent Developments
  25. 8.5 Jiangxi Qingfeng Pharmaceutical
  26. 8.5.1 Jiangxi Qingfeng Pharmaceutical Company Information
  27. 8.5.2 Jiangxi Qingfeng Pharmaceutical Business Overview
  28. 8.5.3 Jiangxi Qingfeng Pharmaceutical Lacosamide Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Jiangxi Qingfeng Pharmaceutical Lacosamide Drugs Product Portfolio
  30. 8.5.5 Jiangxi Qingfeng Pharmaceutical Recent Developments
  31. 8.6 Jiangsu Haian Pharmaceutical
  32. 8.6.1 Jiangsu Haian Pharmaceutical Company Information
  33. 8.6.2 Jiangsu Haian Pharmaceutical Business Overview
  34. 8.6.3 Jiangsu Haian Pharmaceutical Lacosamide Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Jiangsu Haian Pharmaceutical Lacosamide Drugs Product Portfolio
  36. 8.6.5 Jiangsu Haian Pharmaceutical Recent Developments
  37. 8.7 Jianmin Group
  38. 8.7.1 Jianmin Group Company Information
  39. 8.7.2 Jianmin Group Business Overview
  40. 8.7.3 Jianmin Group Lacosamide Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Jianmin Group Lacosamide Drugs Product Portfolio
  42. 8.7.5 Jianmin Group Recent Developments
  43. 8.8 Hefei Yifan Biopharmaceuticals
  44. 8.8.1 Hefei Yifan Biopharmaceuticals Company Information
  45. 8.8.2 Hefei Yifan Biopharmaceuticals Business Overview
  46. 8.8.3 Hefei Yifan Biopharmaceuticals Lacosamide Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Hefei Yifan Biopharmaceuticals Lacosamide Drugs Product Portfolio
  48. 8.8.5 Hefei Yifan Biopharmaceuticals Recent Developments
  49. 8.9 Buchang Pharmaceutical
  50. 8.9.1 Buchang Pharmaceutical Company Information
  51. 8.9.2 Buchang Pharmaceutical Business Overview
  52. 8.9.3 Buchang Pharmaceutical Lacosamide Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Buchang Pharmaceutical Lacosamide Drugs Product Portfolio
  54. 8.9.5 Buchang Pharmaceutical Recent Developments
  55. 8.10 Beijing Sihuan Pharmaceutical
  56. 8.10.1 Beijing Sihuan Pharmaceutical Company Information
  57. 8.10.2 Beijing Sihuan Pharmaceutical Business Overview
  58. 8.10.3 Beijing Sihuan Pharmaceutical Lacosamide Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Beijing Sihuan Pharmaceutical Lacosamide Drugs Product Portfolio
  60. 8.10.5 Beijing Sihuan Pharmaceutical Recent Developments
  61. 8.11 UCB Pharma
  62. 8.11.1 UCB Pharma Company Information
  63. 8.11.2 UCB Pharma Business Overview
  64. 8.11.3 UCB Pharma Lacosamide Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 UCB Pharma Lacosamide Drugs Product Portfolio
  66. 8.11.5 UCB Pharma Recent Developments
  67. 8.12 Teva
  68. 8.12.1 Teva Company Information
  69. 8.12.2 Teva Business Overview
  70. 8.12.3 Teva Lacosamide Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Teva Lacosamide Drugs Product Portfolio
  72. 8.12.5 Teva Recent Developments
  73. 8.13 Sun Pharma
  74. 8.13.1 Sun Pharma Company Information
  75. 8.13.2 Sun Pharma Business Overview
  76. 8.13.3 Sun Pharma Lacosamide Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Sun Pharma Lacosamide Drugs Product Portfolio
  78. 8.13.5 Sun Pharma Recent Developments
  79. 8.14 Sandoz
  80. 8.14.1 Sandoz Company Information
  81. 8.14.2 Sandoz Business Overview
  82. 8.14.3 Sandoz Lacosamide Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Sandoz Lacosamide Drugs Product Portfolio
  84. 8.14.5 Sandoz Recent Developments
  85. 8.15 Mylan
  86. 8.15.1 Mylan Company Information
  87. 8.15.2 Mylan Business Overview
  88. 8.15.3 Mylan Lacosamide Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Mylan Lacosamide Drugs Product Portfolio
  90. 8.15.5 Mylan Recent Developments
  91. 8.16 Glenmark Pharmaceuticals
  92. 8.16.1 Glenmark Pharmaceuticals Company Information
  93. 8.16.2 Glenmark Pharmaceuticals Business Overview
  94. 8.16.3 Glenmark Pharmaceuticals Lacosamide Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Glenmark Pharmaceuticals Lacosamide Drugs Product Portfolio
  96. 8.16.5 Glenmark Pharmaceuticals Recent Developments
  97. 8.17 Camber Pharma
  98. 8.17.1 Camber Pharma Company Information
  99. 8.17.2 Camber Pharma Business Overview
  100. 8.17.3 Camber Pharma Lacosamide Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Camber Pharma Lacosamide Drugs Product Portfolio
  102. 8.17.5 Camber Pharma Recent Developments
  103. 8.18 Aucta Pharma
  104. 8.18.1 Aucta Pharma Company Information
  105. 8.18.2 Aucta Pharma Business Overview
  106. 8.18.3 Aucta Pharma Lacosamide Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Aucta Pharma Lacosamide Drugs Product Portfolio
  108. 8.18.5 Aucta Pharma Recent Developments
  109. 8.19 Apotex
  110. 8.19.1 Apotex Company Information
  111. 8.19.2 Apotex Business Overview
  112. 8.19.3 Apotex Lacosamide Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Apotex Lacosamide Drugs Product Portfolio
  114. 8.19.5 Apotex Recent Developments
  115. 8.20 Actavis
  116. 8.20.1 Actavis Company Information
  117. 8.20.2 Actavis Business Overview
  118. 8.20.3 Actavis Lacosamide Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Actavis Lacosamide Drugs Product Portfolio
  120. 8.20.5 Actavis Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Lacosamide Drugs Value Chain Analysis
  2. 9.1.1 Lacosamide Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Lacosamide Drugs Production Mode & Process
  6. 9.2 Lacosamide Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Lacosamide Drugs Distributors
  9. 9.2.3 Lacosamide Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst